Lasting effects of lost vascular elasticity

Circulation Research

Volumn 100, Issue 5, 2007, Pages 604-606

  Weiss, Robert M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Aneurysm; Aortic valve; Mouse model

Indexed keywords

LOSARTAN;

AORTA ANEURYSM; AORTA DISEASE; AORTA VALVE DISEASE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CELL THERAPY; CLINICAL TRIAL; DEATH; DIABETES MELLITUS; EDITORIAL; GENE REPLACEMENT THERAPY; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; MARFAN SYNDROME; MUTATION; NONHUMAN; PRIORITY JOURNAL; PULSE PRESSURE; STROKE; SYSTOLIC HEART FAILURE; TOBACCO DEPENDENCE; UNITED STATES; ANIMAL; BLOOD VESSEL; ELASTICITY; METABOLISM; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ANIMALS; BLOOD VESSELS; ELASTICITY; ENDOTHELIUM, VASCULAR; HUMANS; VASCULAR DISEASES; VASCULAR RESISTANCE;

EID: 33947731749     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000261611.53084.ad     Document Type: Editorial

References (18)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner K, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y, and for the Am Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics - 2007 Update: A Report From the Am Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:115:e69-e171.
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
3. Heistad DD. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2006;26:689-695.
4. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med. 1994;330:1335-1341.
5. Upchurch Jr GR. Gene therapy to treat aortic aneurysms: right goal, wrong strategy. Circulation. 2005;112: 939-940.
6. www.clinicaltrials.gov Search terms: Aortic Aneurysm and Marfan.
7. Hanada K, Vermeij M, Garinis GA, De Waard MC, Kunen MG, Myers L, Mass A, Duncker DJ, Meijers C, Dietz HC, Kanaar R, Essers J. Perturbations of vascular homeostasis and aortic valve abnormalities in Fibulin-4 deficient mice. Circ Res. 2007;100:738-746.
8. Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY, Urban Z. Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. J Hum Genet. 2006;78:1075-1080.
9. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-121.
10. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355:788-798.
11. Nickenig G, Sachinidis A, Michaelsen F, et al. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation. 1997;95:473-478.
12. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategeis. Circulation. 2005;111:3316-3326.
13. Nickenig G, Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part I: oxidative stress and atherogenesis. Circulation. 2002;105:393-396.
14. Nickenig G, Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part II: AT1 receptor regulation. Circulation. 2002;105:530-536.
15. Lonn EM, Yusuf S, Dzavik V, Doris CI, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley WA, Teo KK. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 2001;103:919-925.
16. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med. 2000;342:145-153.
17. Dai J, Losy F, Guinault A-M, Pages C, Anegon I, Desgranges P, Becquemin J-P, Allaire E. Overexpression of transforming growth factor-β1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005;112:1008-1015.
18. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91:988-998.